These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 9140680

  • 1. Lisinopril in the treatment of congestive heart failure in elderly patients: comparison versus captopril.
    Morisco C, Condorelli M, Crepaldi G, Rizzon P, Zardini P, Villa G, Argenziano L, Trimarco B.
    Cardiovasc Drugs Ther; 1997 Mar; 11(1):63-9. PubMed ID: 9140680
    [Abstract] [Full Text] [Related]

  • 2. Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group.
    Giles TD, Katz R, Sullivan JM, Wolfson P, Haugland M, Kirlin P, Powers E, Rich S, Hackshaw B, Chiaramida A.
    J Am Coll Cardiol; 1989 May; 13(6):1240-7. PubMed ID: 2539403
    [Abstract] [Full Text] [Related]

  • 3. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
    Giles TD, Fisher MB, Rush JE.
    Am J Med; 1988 Sep 23; 85(3B):44-7. PubMed ID: 2844087
    [Abstract] [Full Text] [Related]

  • 4. Long-acting angiotensin-converting enzyme inhibition: once-daily lisinopril versus twice-daily captopril in mild-to-moderate heart failure.
    Bach R, Zardini P.
    Am J Cardiol; 1992 Oct 08; 70(10):70C-77C. PubMed ID: 1329477
    [Abstract] [Full Text] [Related]

  • 5. Lisinopril in the treatment of congestive heart failure.
    Giles TD.
    J Hum Hypertens; 1989 Jun 08; 3 Suppl 1():83-7. PubMed ID: 2550647
    [Abstract] [Full Text] [Related]

  • 6. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.
    Rouleau JL, Pfeffer MA, Stewart DJ, Isaac D, Sestier F, Kerut EK, Porter CB, Proulx G, Qian C, Block AJ.
    Lancet; 2000 Aug 19; 356(9230):615-20. PubMed ID: 10968433
    [Abstract] [Full Text] [Related]

  • 7. A double-blind comparison of lisinopril with captopril in patients with symptomatic congestive heart failure.
    Powers ER, Chiaramida A, DeMaria AN, Giles TD, Hackshaw B, Hart W, Haugland M, Johnston R, Katz R, Kirlin P.
    J Cardiovasc Pharmacol; 1987 Aug 19; 9 Suppl 3():S82-8. PubMed ID: 2442559
    [Abstract] [Full Text] [Related]

  • 8. Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.
    Langtry HD, Markham A.
    Drugs Aging; 1997 Feb 19; 10(2):131-66. PubMed ID: 9061270
    [Abstract] [Full Text] [Related]

  • 9. Quinapril in patients with congestive heart failure: controlled trial versus captopril.
    Acanfora D, Furgi G, Trojano L, Picone C, Iannuzzi GL, Rossi M, Papa A, Rengo C, Rengo F.
    Am J Ther; 1997 Feb 19; 4(5-6):181-8. PubMed ID: 10423609
    [Abstract] [Full Text] [Related]

  • 10. Comparison of lisinopril versus digoxin for congestive heart failure during maintenance diuretic therapy. The Lisinopril-Digoxin Study Group.
    Herlitz J.
    Am J Cardiol; 1992 Oct 08; 70(10):84C-90C. PubMed ID: 1329479
    [Abstract] [Full Text] [Related]

  • 11. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
    Gosse P, Dallocchio M, Gourgon R.
    J Hum Hypertens; 1989 Jun 08; 3 Suppl 1():23-8. PubMed ID: 2550642
    [Abstract] [Full Text] [Related]

  • 12. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure.
    O'Toole L, Stewart M, Padfield P, Channer K.
    J Cardiovasc Pharmacol; 1998 Dec 08; 32(6):988-94. PubMed ID: 9869506
    [Abstract] [Full Text] [Related]

  • 13. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).
    Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI.
    Lancet; 1997 Mar 15; 349(9054):747-52. PubMed ID: 9074572
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of lisinopril and captopril in treatment of severe heart failure (NYHA III-IV) in high risk patients. Preliminary results of the trial].
    Risler T, Braun U, Klärner HG, Müller-Schauenburg W, Heitkamp HC, Brilla GG, Krämer BK, Seipel L.
    Z Kardiol; 1991 Mar 15; 80 Suppl 2():40-3. PubMed ID: 1850942
    [Abstract] [Full Text] [Related]

  • 15. Acute haemodynamic effects of lisinopril and captopril in patients with severe congestive heart failure.
    Van Mieghem W, Van Hedent T, Byttebier G.
    Acta Cardiol; 1993 Mar 15; 48(1):43-53. PubMed ID: 8383397
    [Abstract] [Full Text] [Related]

  • 16. Lisinopril versus placebo in the treatment of heart failure: the Lisinopril Heart Failure Study Group.
    Beller B, Bulle T, Bourge RC, Colfer H, Fowles RE, Giles TD, Grover J, Whipple JP, Fisher MB, Jessup M.
    J Clin Pharmacol; 1995 Jul 15; 35(7):673-80. PubMed ID: 7560247
    [Abstract] [Full Text] [Related]

  • 17. Comparison of treatment with lisinopril versus enalapril for congestive heart failure.
    Zannad F, van den Broek SA, Bory M.
    Am J Cardiol; 1992 Oct 08; 70(10):78C-83C. PubMed ID: 1329478
    [Abstract] [Full Text] [Related]

  • 18. Circadian variation in blood pressure and heart rate in nonhypertensive congestive heart failure.
    Giles TD, Roffidal L, Quiroz A, Sander G, Tresznewsky O.
    J Cardiovasc Pharmacol; 1996 Dec 08; 28(6):733-40. PubMed ID: 8961069
    [Abstract] [Full Text] [Related]

  • 19. [Effectiveness of Lisinopril in the treatment of heart failure].
    Ruszty L, Nagy A, Szónyi T, Vályi P, Poór F, Takács J, Zalaváry I.
    Orv Hetil; 2000 Aug 20; 141(34):1867-72. PubMed ID: 11006711
    [Abstract] [Full Text] [Related]

  • 20. Comparison of lisinopril and captopril in the treatment of left ventricular congestive heart failure--influence of duration of action on efficacy and safety.
    Giles TD.
    Z Kardiol; 1991 Aug 20; 80 Suppl 2():35-9. PubMed ID: 1850941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.